All companies
Visit website
NEUROSITY
OperatingNeurosity, Inc.
Healthcare · Technology · Founded 2018
Mental health minus the medicine
Valuation cap ⓘ
$38.0M
As of Jan 2024 · from NEUROSITY Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$320,709
Across 1 round since 2024
Latest share price
$1.00
NEUROSITY Future Equity SAFE 1 offering price
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$309K
−$811K
2021
$715K
−$2.3M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$309,169
$714,683
Cost of goods sold
$348,698
$1,347,025
Gross margin
-13%
-88%
Net income
-$810,914
-$2,255,067
Taxes paid
$0
$0
Balance sheet
Cash
$182,004
$1,276,166
Accounts receivable
$0
$2,034
Total assets
$711,090
$1,624,108
Short-term debt
$242,600
$256,885
Long-term debt
$1,723,988
$0
Total liabilities
$1,966,588
$256,885
Other
Headcount
—
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$38.0M
Valuation cap
NEUROSITY Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $320.7K / $1.2MInvestors 175Valuation cap $38M
Reg CF annual-report compliance
Delinquent
Filed 0 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2024, 2025
175 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001938793Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.